Edgar Filing: CoroWare, Inc,

j61813010qa1.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q/A

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE OF 1934

For the quarterly period ended September 30, 2012

o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE TRANSITION PERIOD FROM ________________ TO _________________

COMMISSION FILE NUMBER: 000-33231

COROWARE, INC.

(EXACT NAME OF THE COMPANY AS SPECIFIED IN ITS CHARTER)

Delaware	95-4868120
(State or Other Jurisdiction	(I.R.S. Employer
of Incorporation)	Identification No.)

1410 Market Street, Suite 200

Kirkland, WA 98033

(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES)

(800) 641-2676

(ISSUER REGISTRANT TELEPHONE NUMBER)

Indicate by check mark whether the Company (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Company was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. x Yes o No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer o	Accelerated filer o
Non-accelerated filer o (Do not check if a smaller reporting company	Smaller reporting company x

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yeso No x

As of November 16, 2012 there were 211,102,389 shares of the issuer's $.0001 par value common stock outstanding.

This amendment is to correct minor typographical errors in the original filing.

COROWARE, INC.

September 30, 2012 QUARTERLY REPORT ON FORM 10-Q

TABLE OF CONTENTS

		PAGE

PART I – FINANCIAL INFORMATION		2

Item 1.	Consolidated Financial Statements	2
	Consolidated Balance Sheets at September 30, 2012 (Unaudited) and December 31, 2011	2

	Unaudited Consolidated Statements of Operations for the three and nine months ended September 30, 2012 and 2011	3

	Unaudited Consolidated Statements of Cash Flows for the nine months ended September 30, 2012 and 2011	4

	Notes to Unaudited Consolidated Financial Statements	6

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	16

Item 3.	Quantitative and Qualitative Disclosures About Market Risk	19

Item 4.	Controls and Procedures	20

PART II – OTHER INFORMATION		21

Item 1.	Legal Proceedings	21

Item 1A.	Risk Factors	21

Item 2.	Unregistered Sales of Equity Securities and Use of Funds	21

Item 3.	Defaults Upon Senior Securities	21

Item 4.	Mine Safety Disclosures	22

Item 5.	Other Information	22

Item 6.	Exhibits	22

SIGNATURES		23

COROWARE, INC.

CONSOLIDATED BALANCE SHEETS

	September 30,		December 31,
	2012		2011
	(Unaudited)
ASSETS

Current assets:
Cash	$	2,927	$	522
Accounts receivable, net		141,165		129,438
Inventory		2,190		3,783
Other current assets		21,109		7,518
Total current assets		167,391		141,261

Property and equipment, net		16,704		24,333
Other assets, net		56,273		6,927

TOTAL ASSETS	$	240,368	$	172,521

LIABILITIES AND STOCKHOLDERS’ DEFICIT

Current liabilities:
Lines of credit	$	123,359	$	125,456
Obligations collateralized by receivables		170,122		107,730
Accounts payable and accrued expenses		5,004,259		4,442,906
Accrued expenses, related parties		183,929		111,466
Notes payable		209,732		202,232
Notes payable, related parties		205,741		208,913
Derivative liability		8,766,164		2,798,366
Current maturities of convertible debt, net of discount		2,205,350		2,206,247
Redeemable preferred stock, Series B, $.001 par value, 10,000,000 shares authorized, 159,666 shares issued and outstanding as of September 30, 2012 and December 31, 2011		397,390		106,443
Redeemable preferred stock, Series D, $.001 par value, 500,000 shares authorized, 100,000 shares issued and outstanding as of September 30, 2012 and December 31, 2011		223,330		75,901
Redeemable preferred stock, Series E, $.001 par value, 1,000,000 shares authorized, 10,000 and -0- shares issued and outstanding, respectively, as of September 30, 2012 and December 31, 2011		1,400		-
Small Business Administration Loan		980,450		980,450
Total current liabilities		18,471,226		11,366,110

Long term liabilities:
Convertible debt, net of discount and current portion		221,805			149,107
Total liabilities		18,693,031			11,515,217

Commitments

Stockholders’ deficit:
Common stock, $.0001 par value, 3,000,000,000 shares authorized,
101,813,955 and 3,980,589 shares issued and 101,813,951 and 3,980,585 outstanding at September 30, 2012 and
December 31, 2011, respectively		10,182			398
Additional paid-in capital		16,537,111			16,159,171
Accumulated deficit		(34,964,256	)		(27,466,565	)
Treasury stock		(35,700	)		(35,700	)
Total stockholders’ deficit		(18,452,663	)		(11,342,696	)

TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT	$	240,368		$	172,521

The accompanying notes are an integral part of these consolidated financial statements.

COROWARE, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
For the Three and Nine Months ended September 30, 2012 and 2011 (Unaudited)
	Three Months Ended September 30,						Nine Months Ended September 30,
	2012			2011			2012			2011

Revenues	$	224,136		$	389,089		$	910,655		$	1,277,358
Cost of revenues		179,098			289,945			595,459			849,347

Gross profit		45,038			99,144			315,196			428,011

Operating expenses:
General and administrative		177,636			182,588			516,109			658,083
Sales and marketing		57,236			68,824			192,875			251,322
Research and development		12,309			20,372			57,391			106,562
Depreciation and amortization		3,000			3,000			9,000			20,081
Total operating expenses		250,181			274,784			775,375			1,036,048

Loss from operations		(205,143	)		(175,640	)		(460,179	)		(608,037	)



Other income (expense):
Derivative expense		(6,228,894	)		(2,561,925	)		(6,568,388	)		(3,021,883	)
Interest expense, net		(157,303	)		(198,518	)		(527,021	)		(567,600	)
Gain (Loss) on settlement of liabilities and mortgage note		(15,272	)		-			(13,172	)		(76,582	)
Gain (loss) on convertible debt redemptions		106,700			114			71,070			75,517
Total other expense		(6,294,769	)		(2,760,329	)		(7,037,511	)		(3,590,548	)

Net loss	$	(6,499,912	)	$	(2,935,969	)	$	(7,497,690	)	$	(4,198,586	)

Net loss per share:
Basic	$	(0.27	)	$	(0.62	)	$	(0.53	)	$	(1.68	)
Weighted average shares outstanding:
Basic		23,689,883			4,705,474			14,126,220			2,503,438

COROWARE, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
For the Nine Months Ended September 30, 2012 and 2011
(Unaudited)

	2012			2011

CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$	(7,497,690	)	$	(4,198,586	)
Adjustments to reconcile net income to net cash flows
from operating activities:
Depreciation and amortization		9,000			20,081
Amortization of debt discount		166,618			205,123
Amortization of deferred financing costs		5,370			5,499
Derivative expense		6,568,387			3,021,883
Gain on convertible debt redemptions		(71,070	)		(75,516	)
Common stock issued for services		13,000			3,300
Loss on settlement of liabilities with stock		13,172			75,134
Changes in operating assets and liabilities:
Accounts receivable, net		(11,727	)		36,123
Other current assets, net		1,002			(2,909	)
Accounts payable and accrued expenses		642,638			860,101
Accrued expenses, related parties		72,463			(8,155	)
NET CASH FLOWS FROM OPERATING ACTIVITIES		(88,837	)		(57,922	)

CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property and equipment		(1,371	)		(3,626	)
NET CASH FLOWS FROM INVESTING ACTIVITIES		(1,371	)		(3,626	)


CASH FLOWS FROM FINANCING ACTIVITIES
Obligations collateralized by receivables		62,392			(6,593	)
(Repayment of) proceeds from lines of credit, net		(2,097	)		3,789
Payments on notes payable		(1,500	)		(8,692	)
Payments on notes payable, related parties		(3,172	)		(3,342	)
Payments on long-term debt		-			(2,000	)
Proceeds from convertible debentures, net of financing costs		17,990			80,000
Proceeds from notes payable		9,000			15,000
Proceeds from sale of preferred stock, Series E		10,000			-
NET CASH FLOWS FROM FINANCING ACTIVITIES		92,613			78,162

NET INCREASE IN CASH		2,405			16,614
Cash, beginning of period		522			-
Cash, end of period	$	2,927		$	16,614

Continued.

COROWARE, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS (continued)

For the Nine Months Ended September 30, 2012 and 2011

(Unaudited)

	2012		2011
SUPPLEMENTAL CASH FLOW INFORMATION
Interest paid	$	-	$	-
Income taxes paid	$	-	$	-

NON-CASH INVESTING AND FINANCING TRANSACTIONS
Common stock issued for redemption of convertible debentures	$	278,705	$	330,669
Common stock issued in satisfaction of accrued liabilities	$	34,540	$	280,849
Common stock issued as contribution into joint venture	$	49,400	$	-

The accompanying notes are an integral part of these consolidated financial statements.

COROWARE, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

NOTE 1 – BASIS OF PRESENTATION

The accompanying unaudited interim consolidated financial statements of CoroWare, Inc. (“CoroWare” or “the Company”) have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules of the Securities and Exchange Commission (“SEC”), and should be read in conjunction with the audited financial statements and notes thereto contained in the Company’s annual report filed with the SEC on Form 10-K for the year ended December 31, 2011. The consolidated financial statements include the accounts of the Company and its wholly-owned operating subsidiary, CoroWare Technologies, Inc. Also included in the consolidated statements are the Company’s inactive wholly-owned subsidiaries, Innova Robotics, Inc., Robotic Workspace Technologies, Inc., and Robotics Software Service, Inc. (herein referred to as the “Subsidiaries”). In the opinion of management, all adjustments consisting of normal recurring adjustments necessary for a fair presentation of financial position and the results of operations for the interim periods presented have been reflected herein. The results of operations for interim periods are not necessarily indicative of the results to be expected for the full year. Notes to the financial statements which would substantially duplicate the disclosure contained in the audited financial statements for the most recent fiscal year ended December 31, 2011 as reported in Form 10-K have been omitted.

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Subsequent Events

The Company evaluated events occurring between the end of the current period and the date these financial statements were issued for potential subsequent event disclosures.

Recent Accounting Pronouncements

Management does not expect the impact of any other recently issued accounting pronouncements to have a material impact on its financial condition or results of operations.

Reclassifications

Certain 2011 balances have been restated to conform to current year presentation.

NOTE 3 – FINANCIAL CONDITION AND GOING CONCERN

The Company has a loss from operations for the nine months ended September 30, 2012 of $460,179. Because of this loss, the current working capital deficit, and the projection of additional losses for the remainder of 2012, the Company will require additional working capital to develop its business operations.

The Company intends to raise additional working capital through the use of public offerings and/or related party financings.

There are no assurances that the Company will be able to either (1) achieve a level of revenues adequate to generate sufficient cash flow from operations; or (2) obtain additional financing through either private placements, public offerings, bank financing and/or related party financing necessary to support the Company's working capital requirements. To the extent that funds generated from operations, any private placements, public offerings, bank financing and/or related party financings are insufficient, the Company will have to raise additional working capital. No assurance can be given that additional financing will be available or, if available, will be on terms acceptable to the Company.

These conditions raise substantial doubt about the Company's ability to continue as a going concern. The consolidated financial statements do not include any adjustments relating to the recoverability and classification of asset carrying amounts or the amount and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

NOTE 4 – ACCOUNTS RECEIVABLE FACTORING

On March 21, 2010, the Company established a $200,000 factoring line with an asset-based lender, CapeFirst Funding, LLC (“Capefirst”) that is secured by accounts receivable that the Lender may accept and purchase from the Company. The agreement calls for Capefirst to advance up to 80% of the net face amount of each assigned account or up to 50% of eligible assigned purchase orders. The agreement calls for a maximum facility amount of $200,000 with a purchase fee of 2% of the net face amount of each assigned account and a collection fee of 0.1% compounded daily. In the event of a dispute or in the event of fraud, misrepresentation, willful misconduct or negligence on the part of the Company, Capefirst may require the Company to immediately repurchase the assigned accounts at a purchase price that includes the amount of the assigned account plus the discount fee, interest and collection fee and may include a processing fee of 10%. The combined balance due to factors as of September 30, 2012 and December 31, 2011 was $170,102 and $107,730. Factor expense charged to operations for the three and nine month periods ended September 30, 2012 aggregated $5,814 and $24,830.

NOTE 5 - CONVERTIBLE DEBT

The following table illustrates the carrying value of convertible debt:

		September 30, 2012			December 31, 2011
$2,825,000 Yorkville financing		$	471,543		$	478,258
$ 600,000 Yorkville financing			600,000			600,000
$ 300,000 Yorkville financing			300,000			300,000
$ 75,000 Collins financing			39,169			34,679
$ 17,500 Asher financing	(a)		2,499			-
$ 20,000 Asher financing	(b)		18,695			-
$ 27,500 Asher financing	(c)		18,102			19,951
$ 10,750 Barclay financing			10,750			10,750
$ 9,750 Tangiers financing	(d)		3,059			8,524
$ 170,562 Ratzker financing			118,655			79,319
$ 67,042 Harvey financing			67,043			62,675
$ 89,383 Cariou financing			54,838			83,077
$ 10,000 Tangiers financing			-			7,895
$ 15,000 Tangiers financing			-			10,764
$ 65,000 Panache financing	(e)		47,388			29,602
$ 15,000 Panache financing			15,000			5,612
$ 567,200 Westmount financing			537,318			537,318
$ 170,561 Redwood financing	(f)		77,146			69,788
$ 21,962 Premier financing			21,805			17,142
$ 21,000 Tangiers financing			6,043			-
$ 5,474 Tangiers financing			2,500			-
$ 10,000 Magna financing	(g)		10,000			-
$ 54,060 Ridge Point financing	(h)		4,962			-
			2,426,515			2,355,354
Less: Current portion of convertible debt			(2,204,710	)		(2,206,247	)
Long term portion of convertible debt		$	221,805		$	149,107

(a)	$17,500 Asher financing:

On August 9, 2012, the Company consummated an unsecured Securities Purchase Agreement with an unrelated third party for the sale by the Company of its 8% secured convertible debentures in the aggregate principal amount of $17,500, net of deferred financing costs of $2,500.

The debenture matures on May 13, 2013, nine months from the date of issuance. The holder of the debenture may, at any time, convert amounts outstanding under the debenture into shares of common stock of the Company at a conversion rate equal to 50% of the market price, which is defined as the average of the lowest 3 trading prices for the Company’s common stock during the 30 trading days prior to conversion.

In the Company’s evaluation of this instrument in accordance with ASC 815 Derivatives and Hedging, based on the variable conversion price and lack of authorized shares, it was determined that the conversion feature was not afforded the exemption as a conventional convertible instrument and did not otherwise meet the conditions for equity classification. As such, the conversion and other features were compounded into one instrument, bifurcated from the debt instrument and carried as a derivative liability, at fair value. The Company estimated the fair value of the bifurcated derivative instruments using the Monte Carlo valuation model because this methodology provides for all of the necessary assumptions necessary for fair value determination; including assumptions for credit risk, interest risk and conversion/redemption behavior. Significant assumptions underlying this methodology were: effective term (using the remaining term of the host instrument); effective volatility (222.71% - 212.43%); and effective risk adjusted yield (12.5%). As a result of these estimates, the valuation model resulted in a compound derivative balance of $15,452 at inception. There was no derivative expense recognized at inception.

There were no conversions on this instrument during the three month period ending September 30, 2012.

(b)	$20,000 Asher financing:

On August 2, 2012, Cariou sold $20,000 of his convertible note to Asher. In connection with the sale, the Company restated the interest rate on the note from 15% to 10% and changed the conversion rate from the 5 day average closing price using the 5 trading days prior to conversion to 40% of the Market Price (defined as the average of the (1) lowest trading price for common stock during the 30 day trading period ending one trading day prior to the date of conversion). Additionally, the beneficial ownership limit was increased from 4.99% to 9.99%.

During the three month period ending September 30, 2012, Asher converted $1,225 of the convertible debenture into 3,208,333 shares of the Company’s common stock. The Company recognized a loss on redemption of $4,141.

(c)	$27,500 Asher financing:

During the quarter, the convertible note was modified to increase the beneficial ownership limit from 4.99% to 9.99%.

During the three month period ending September 30, 2012, Asher converted $3,600 of the convertible debenture into 8,780,488 shares of the Company’s common stock. The Company recognized a gain on redemption of $87,320.

(d)	$9,750 Tangiers financing:

During the three month period ending September 30, 2012, Tangiers converted $5,245 of the convertible debenture into 13,221,424 shares of the Company’s common stock. The Company recognized a gain on redemption of $1,106.

(e)	$170,561 Redwood financing:

During the three month period ending September 30, 2012, Panache converted $5,585 of the convertible debenture into 3,212,236 shares of the Company’s common stock. The Company recognized a gain on redemption of $7,561.

(f)	$65,000 Panache financing:

During the three month period ending September 30, 2012, Panache converted $4,880 of the convertible debenture into 3,265,000 shares of the Company’s common stock. The Company recognized a gain on redemption of $14,852.

(g)	$10,000 Magna financing:

On August 20, 2012, Cariou sold $10,000 of his convertible note to Magna Group, LLC (“Magna”). In connection with the sale, the maturity date was extended from May 4, 2011 to April 20, 2013, the Company restated the interest rate on the note from 15% to 12% and changed the conversion rate from the 5 day average closing price using the 5 trading days prior to conversion to 60% of the lowest trading price for common stock during the 3 trading days prior to the date of conversion. Additionally, if the stock is chilled by the DTC at any point in which this agreement is outstanding, the discount increases by an additional 8%.

There were no conversions on this instrument during the three month period ending September 30, 2012.

(h)	$54,060 Ridge Point financing:

On August 30, 2012, the Company entered into a $54,060 convertible note with LBB & Associates (“LBB”). The note bears interest at 10% and matures March 24, 2013. The note is convertible into common stock of the Company at a conversion rate equal to 65% of the average of the lowest two trading price for common stock during the 5 day trading period prior to the date of conversion.

On September 21, 2012, LBB sold this note to Ridge Point Capital. During the three month period ending September 30, 2012, there were no conversions on this debenture.

The following tables illustrate the fair value adjustments that were recorded related to the derivative financial instruments associated with the convertible debenture financings:

	Three Months ended September 30, 2012
Derivative income (expense):	Inception			Fair Value Adjustments			Redemptions			Total
$2,825,000 Yorkville financing (a)	$	-		$	(1,596,351	)	$	-		$	(1,596,351	)
$ 600,000 Yorkville financing		-			(684,871	)		-			(684,871	)
$ 300,000 Yorkville financing		-			-			-			-
$ 75,000 Collins financing		-			(88,632	)		-			(88,632	)
$ 17,500 Asher financing		-			(59,471	)		-			(59,471	)
$ 20,000 Asher financing		(62,980	)		(32,754	)		(971	)		(96,705	)
$ 27,500 Asher financing (b)		-			(62,079	)		(108,311	)		(170,390	)
$ 10,750 Barclay financing (c)		-			(13,025	)		-			(13,025	)
$ 9,750 Tangiers financing (d)		-			(28,636	)		(10,462	)		(39,098	)
$ 170,562 Ratzker financing (e)		-			(368,772	)		-			(368,772	)
$ 67,042 Harvey financing (f)		-			(60,090	)		-			(60,090	)
$ 89,383 Cariou financing (g)		-			(24,193	)		-			(24,193	)
$ 10,000 Tangiers financing (i)		-			-			-			-
$ 15,000 Tangiers financing (j)		-			-			-			-
$ 65,000 Panache financing (k)		-			(167,097	)		(21,812	)		(188,909	)
$ 15,000 Panache financing (l)		-			(29,427	)		-			(29,427	)
$ 567,200 Westmount financing (m)		-			(1,756,385	)		-			(1,756,385	)
$ 170,561 Redwood financing (n)		-			(494,302	)		(12,857	)		(507,159	)
$ 21,962 Premier financing		-			(11,535	)		-			(11,535	)
$ 21,000 Tangiers financing		-			(78,291	)		-			(78,291	)
$ 5,000 Tangiers financing		-			(10,788	)		-			(10,788	)
$ 10,000 Magna financing		(13,267	)		(21,210	)		-			(34,477	)
$ 54,060 Ridge Point financing		(9,846	)		(118,893	)		-			(128,739	)
Preferred stock, Series B		-			(184,503	)		-			(184,503	)
Preferred stock, Series D		-			(105,683	)		-			(105,683	)
Preferred stock, Series E		-			8,600			-			8,600
	$	(86,093	)	$	(5,988,388	)	$	(154,413	)	$	(6,228,894	)

	Three Months ended September 30, 2011
Derivative income (expense):	Inception		Fair Value Adjustments			Redemptions			Total
$2,825,000 Yorkville financing	$	-	$	(550,989	)	$	-		$	(550,989	)
$ 600,000 Yorkville financing		-		(797,107	)		-			(797,107	)
$ 300,000 Yorkville financing		-		-			-			-
$ 75,000 Collins financing		-		(40,046	)		-			(40,046	)
$ 27,500 Asher financing		-		(20,294	)		(2,976	)		(23,270	)
$ 10,750 Barclay financing		-		(2,829	)		-			(2,829	)
$ 9,750 Mackie financing		-		(900	)		-			(900	)
$ 170,562 Ratzker financing		-		(97,539	)		-			(97,539	)
$ 67,042 Harvey financing		-		(11,839	)		-			(11,839	)
$ 89,383 Cariou financing		-		(7,299	)		-			(7,299	)
$ 10,000 Tangiers financing		-		(3,009	)		-			(3,009	)
$ 15,000 Tangiers financing		-		(8,292	)		-			(8,292	)
$ 25,000 Tangiers financing		-		-			-			-
$ 65,000 Panache financing		-		(86,638	)		-			(86,638	)
$ 15,000 Panache financing		-		(11,395	)		-			(11,395	)
$ 567,200 Westmount financing		-		(561,796	)		-			(561,796	)
$ 170,561 Redwood financing		-		(60,934	)		-			(60,934	)
Preferred stock, Series B		-		(298,043	)		-			(298,043	)
	$	-	$	(2,558,949	)	$	(2,976	)	$	(2,561,925	)

	Nine Months ended September 30, 2012
Derivative income (expense):	Inception			Fair Value Adjustments			Redemptions			Total
$2,825,000 Yorkville financing	$	-		$	(1,665,967	)	$	(6,029	)	$	(1,671,996	)
$ 600,000 Yorkville financing		-			(812,222	)		-			(812,222	)
$ 300,000 Yorkville financing		-						-			-
$ 75,000 Collins financing		-			(96,596	)		-			(96,596	)
$ 17,500 Asher financing		-			(59,471	)		-			(59,471	)
$ 20,000 Asher financing		(62,980	)		(32,754	)		(971	)		(96,705	)
$ 27,500 Asher financing		-			(65,169	)		(108,311	)		(173,480	)
$ 10,750 Barclay financing		-			(23,290	)		-			(23,290	)
$ 9,750 Tangiers financing		-			(38,554	)		(10,462	)		(49,016	)
$ 170,562 Ratzker financing		-			(369,735	)		(2,429	)		(372,164	)
$ 67,042 Harvey financing		-			(71,337	)		-			(71,337	)
$ 89,383 Cariou financing		-			(35,572	)		-			(35,572	)
$ 10,000 Tangiers financing		-			18,941			(7,213	)		11,728
$ 15,000 Tangiers financing		-			15,820			(12,450	)		3,370
$ 65,000 Panache financing		-			(161,362	)		(27,693	)		(189,055	)
$ 15,000 Panache financing		-			(28,305	)		-			(28,305	)
$ 567,200 Westmount financing		-			(1,669,240	)		-			(1,669,240	)
$ 170,561 Redwood financing		-			(437,001	)		(81,057	)		(518,058	)
$ 21,962 Premier financing		-			(19,771	)		-			(19,771	)
$ 21,000 Tangiers financing		(18,480	)		(66,550	)		-			(85,030	)
$ 5,000 Tangiers financing		(9,417	)		(5,060	)		(4,708	)		(19,185	)
$ 10,000 Magna financing		(13,267	)		(21,210	)		-			(34,477	)
$ 54,060 Ridge Point financing		(9,846	)		(118,893	)		-			(128,739	)
Preferred stock, Series B		-			(290,947	)		-			(290,947	)
Preferred stock, Series D		-			(147,429	)		-			(147,429	)
Preferred stock, Series E					8,600			-			8,600
	$	(113,990	)	$	(6,193,074	)	$	(261,323	)	$	(6,568,387	)

	Nine Months ended September 30, 2011
Derivative income (expense):	Inception			Fair Value Adjustments			Redemptions			Total
$2,825,000 Yorkville financing	$	-		$	(244,386	)	$	(23,917	)	$	(268,303	)
$ 600,000 Yorkville financing		-			(599,854	)		-			(599,854	)
$ 300,000 Yorkville financing		-			26			-			26
$ 75,000 Collins financing		-			(35,461	)		(22,742	)		(58,203	)
$ 27,500 Asher financing		(9,229	)		(24,483	)		(2,976	)		(36,688	)
$ 10,750 Barclay financing		(1,619	)		(1,844	)		-			(3,463	)
$ 9,750 Mackie financing		-			(2,288	)		-			(2,288	)
$ 170,562 Ratzker financing		-			(138,784	)		-			(138,784	)
$ 67,042 Harvey financing		-			(12,330	)		-			(12,330	)
$ 89,383 Cariou financing		-			(3,420	)		-			(3,420	)
$ 10,000 Tangiers financing		-			(12,624	)		-			(12,624	)
$ 15,000 Tangiers financing		-			(20,579	)		-			(20,579	)
$ 25,000 Tangiers financing		(1,662	)		22,462			-			20,800
$ 65,000 Panache financing		(35,880	)		(63,178	)		(11,342	)		(110,410	)
$ 15,000 Panache financing		-			(7,559	)		-			(7,559	)
$ 567,200 Westmount financing		-			(1,091,001	)		(42,054	)		(1,133,055	)
$ 170,561 Redwood financing		-			(402,840	)		(67,492	)		(470,332	)
Preferred stock, Series B		-			(164,817	)		-			(164,817	)
	$	(48,390	)	$	(2,802,960	)	$	(170,533	)	$	(3,021,883	)

The following table illustrates the components of derivative liabilities:

	As of September 30, 2012
	Compound Derivative		Warrant Liability		Total
$2,825,000 Yorkville financing	$	2,273,980	$	-	$	2,273,980
$ 600,000 Yorkville financing		1,392,332		12,023		1,404,355
$ 300,000 Yorkville financing		-		-		-
$ 75,000 Collins financing		137,268		-		137,268
$ 17,500 Asher financing		74,923		-		74,923
$ 20,000 Asher financing		95,734		-		95,734
$ 27,500 Asher financing		98,497		-		98,497
$ 10,750 Barclay financing		31,232		-		31,232
$ 9,750 Tangiers financing		43,816		-		43,816
$ 170,562 Ratzker financing		573,469		-		573,469
$ 67,042 Harvey financing		110,134		-		110,134
$ 89,383 Cariou financing		87,521		-		87,521
$ 65,000 Panache financing		247,512		-		247,512
$ 15,000 Panache financing		41,148		-		41,148
$ 567,200 Westmount financing		2,455,140		-		2,455,140
$ 170,561 Redwood financing		724,328		-		724,328
$ 21,962 Premier financing		29,325		-		29,325
$ 21,000 Tangiers financing		106,030		-		106,030
$ 5,474 Tangiers financing		14,476		-		14,476
$ 10,000 Magna financing		34,477		-		34,477
$ 54,060 Ridge Point financing		182,799		-		182,799
	$	8,754,141	$	12,023	$	8,766,164

The following table illustrates the components of derivative liabilities at December 31, 2011:

	Compound derivative		Warrant liability		Total
$2,825,000 Yorkville financing		608,013		-		608,013
$ 600,000 Yorkville financing		586,883		5,250		592,133
$ 300,000 Yorkville financing		-		-		-
$ 75,000 Collins financing		40,672		-		40,672
$ 27,500 Asher financing		33,328		-		33,328
$ 10,750 Barclay financing		7,942		-		7,942
$ 9,750 Mackie financing		5,262		-		5,262
$ 170,562 Ratzker financing		203,734		-		203,734
$ 67,042 Harvey financing		38,797		-		38,797
$ 89,383 Cariou financing		51,949		-		51,949
$ 10,000 Tangiers financing		18,941		-		18,941
$ 15,000 Tangiers financing		15,821		-		15,821
$ 65,000 Panache financing		86,149		-		86,149
$ 15,000 Panache financing		12,843		-		12,843
$ 567,200 Westmount financing		785,900		-		785,900
$ 170,561 Redwood financing		287,328		-		287,328
$ 21,962 Premier financing		9,554		-		9,554
		2,793,116		5,250		2,798,366

The following table summarizes the number of common shares indexed to the derivative financial instruments as of September 30, 2012:

Financing or other contractual arrangement:	Conversion Features		Warrants		Total
$2,825,000 Yorkville financing		1,120,213,254		-		1,120,213,254
$ 600,000 Yorkville financing		736,294,371		5,250,000		741,544,371
$ 300,000 Yorkville financing		406		33,333		33,739
$ 75,000 Collins financing		67,321,440		-		67,321,440
$ 17,500 Asher financing		35,391,233		-		35,391,233
$ 20,000 Asher financing		47,700,137		-		47,700,137
$ 27,500 Asher financing		46,548,973		-		46,548,973
$ 10,750 Barclay financing		15,569,370		-		15,569,370
$ 9,750 Tangiers financing		13,370,706		-		13,370,706
$ 170,562 Ratzker financing		293,334,441		-		293,334,441
$ 67,042 Harvey financing		62,293,012		-		62,293,012
$ 89,383 Cariou financing		46,529,127		-		46,529,127
$ 65,000 Panache financing		116,971,485		-		116,971,485
$ 15,000 Panache financing		19,391,459		-		19,391,459
$ 567,200 Westmount financing		1,156,993,485		-		1,156,993,485
$ 170,561 Redwood financing		325,883,788		-		325,883,788
$ 21,962 Premier financing		15,590,426		-		15,590,426
$ 21,000 Tangiers financing		43,651,628		-		43,651,628
$ 5,474 Tangiers financing		5,959,912		-		5,959,912
$ 10,000 Magna financing		14,899,275		-		14,899,275
$ 54,060 Ridge Point financing		83,852,813		-		83,852,813
Preferred Stock, Series B		141,925,333		-		141,925,333
Preferred Stock, Series D		79,760,718		-		79,760,718
Preferred Stock, Series E		500,000		-		500,000
		4,489,896,792		5,283,333		4,495,180,125

The embedded conversion features associated with our convertible debentures are valued based on the number of shares that are indexed to that liability. Keeping the number of shares constant, the liability associated with the embedded conversion features increases as our share price increases and, likewise, decreases when our share price decreases. In the same manner, derivative expense is created when our share price increases and derivative income is created when our share price decreases.

During the nine months ended September 30, 2012, conversions were as follows:

Financing or other contractual arrangement:	Principal converted		Shares Issued		Gain (Loss) Recorded

$2,825,000 Yorkville convertible note financing	$	6,715		395,000	$	4,844
$ 65,000 Panache convertible note financing		8,980		3,675,000		7,536
$ 170,562 Ratzker convertible note financing		3,900		300,000		(2,531	)
$ 10,000 Tangiers convertible note financing		10,000		500,000		2,033
$ 15,000 Tangiers convertible note financing		15,000		750,000		7,715
$ 170,561 Redwood convertible note financing		44,485		6,208,390		(19,547	)
$ 5,474 Tangiers convertible note financing		2,500		500,000		(13,267	)
$ 20,000 Asher convertible note financing		1,225		3,208,333		(4,140	)
$ 27,500 Asher convertible note financing		3,600		8,780,488		87,320
$ 9,750 Tangiers convertible note financing		5,245		13,221,424		1,106
	$	101,650		37,538,635	$	71,070

As noted above, the following notes are in default: the remaining balance of the $2,825,000 financing, the $600,000 and $300,000 Yorkville financings, the $75,000 Collins financing, the $27,500 Asher financing, the $10,750 Barclay financing, the $567,200 Westmount financing, the $67,042 Harvey financing, the $65,000 and $15,000 Panache financings, the Tangiers $9,750 financing, the $21,962 Premier financing and the $89,383 Cariou financing. However, the terms of the agreements allow conversion of the debt during periods of default. In computing the derivative liability associated with the conversion, one of the inputs is maturity of the instruments which, in this case, is technically in the past. Accordingly, management has estimated a debt maturity date of ten months from the period-end date for purposes of the derivative liability calculations.

NOTE 6 – INVESTMENT IN JOINT VENTURE

On September 27, 2012, CoroWare announced that it has partnered with a private investor to launch a joint venture - ARICON, LLC - that is headquartered in Charlotte, North Carolina, and that will develop and market mobile robot platforms, applications, and solutions for the construction industry.

The joint venture is currently comprised of CoroWare (51% ownership), who agreed to contribute 38,000,000 shares of restricted CoroWare common stock, (1) mobile robot for prototype development, $10,000 cash, and mobile robotics development expertise; and Lucas Snyder (49% ownership), a private investor who agreed to contribute $50,000 cash, construction industry expertise, and customer relationships.

Through its combined expertise in construction and robotics, ARiCON intends to address the growing need for Computer Aided Production (CAP) solutions, with its initial focus on the development of robotic layout systems.

NOTE 7 - OTHER STOCKHOLDERS’ EQUITY

a)	Stock Options:

The following table summarizes stock option activity:

	Total Options		Weighted Average Price
Outstanding, December 31, 2011		38,164	$	2.97
Granted		-		-
Cancelled		-		-
Forfeited		-		-
Exercised		-		-
Outstanding, September 30, 2012		38,164	$	2.97
Exercisable at September 30, 2012		38,164	$	2.97

b)	Outstanding warrants:

At September 30, 2012, the Company had the following warrants outstanding:

	Grant Date	Expiration Date		Warrants Granted				Exercise Price
$ 300,000 financing	03/19/08	03/19/13			167			$	1,200

c)	Issuance of common stock:

The following table summarizes common stock issued for services during the nine month period ended September 30:

	2012				2011
	Shares		Value		Shares		Value
Employee compensation		-	$	-		5,000	$	3,300
Investor relations		14,258,949		18,281
Legal services		400,000		6,800		-		-
		14,658,949	$	25,081		5,000	$	3,300

The following table summarizes other common stock issued during the nine month period ended September 30:

	2012				2011
	Shares		Value		Shares		Value
Satisfaction of payables		7,634,882	$	34,540		983,946	$	280,851
Redemption of convertible debentures		37,539,530		278,705		2,548,690		330,669
Contribution into joint venture		38,000,000		49,400		-		-
		83,174,412	$	362,645		3,532,636	$	611,520

As a result of the issuances noted above, substantial dilution of existing stockholders’ interests has occurred.

d)	Dividends on preferred stock:

At September 30, 2012 and December 31, 2011, there were cumulative undeclared dividends to Preferred Series B shareholders of $45,904 and $39,917, respectively. Additionally, there were cumulative undeclared dividends to Preferred Series B shareholders of $250 and $0, respectively at September 30, 2012 and December 31, 2011. These obligations are contingent on declaration by the board of directors.

e)	Preferred Stock, Series E:

On March 9, 2012 the Board approved by unanimous written consent an amendment to the Corporation’s Certificate of Incorporation to designate the rights and preferences of Series E Preferred Stock. There are 1,000,000 shares of Series E Preferred Stock authorized with a par value of $0.001. Each share of Series E Preferred Stock has a stated value equal to $1.00 and shall be entitled to receive dividends at the rate of 5% per annum on the stated value before dividends are declared on any other outstanding shares of stock of the Company. These preferred shares rank higher than the common shares and pari passu with all other classes of preferred stock. The Conversion Price for each share of Series E Preferred Stock in effect on any Conversion Date shall be 50% of the lowest closing bid price of the Common Stock on the principal trading exchange or market for the Common Stock for the twenty (20) trading days prior to but not including the Conversion Date, but in no case lower than the par value of the Common Stock. Mandatory conversion can be demanded by the Company prior to October 1, 2013. The holders of the Series E Preferred Stock shall have no voting power.

During the quarter ending September 30, 2012, there were no sales of Series E preferred shares.

f)	Increase in Authorized Shares and Change in Par Value:

On November 11, 2011, the Majority Stockholders authorized an increase in the number of authorized shares of common stock from nine hundred million (900,000,000) shares of common stock to three billion (3,000,000,000) shares of common stock. In addition, the par value of common stock changed from a par value $0.001 per share to a par value $0.0001 per share. This change was effective January 3, 2012. All common share amounts within this document have been adjusted to reflect this change.

g)	Reverse split:

On July 6, 2012, the Company effected a one-for-two hundred (1:200) reverse split of the Company’s Common Stock. All common share amounts within this document have been adjusted to reflect this change.

NOTE 8 – COMMITMENTS

The Company leases its principal operating facilitates in Kirkland, Washington under a 5 year operating lease which runs through July 31, 2015 and provides for monthly payments of $3,735 with a built in annual escalation clause increasing monthly rent by $249 at each anniversary date.

Future non-cancelable minimum lease payments are as follows:

Years Ending December 31,
2012		37,101
2013		52,041
2014		55,029
2015		33,117
	$	177,288

NOTE 9 – SUBSEQUENT EVENTS

Stock Issuances:

As of November 16, 2012, the Company issued 33,541,219 shares subsequent to September 30, 2012 in connection with redemptions of convertible debentures and 75,747,019 shares for services.

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

This report contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements relate to future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology such as "may" "should," "expect," "plan," "anticipate," "believe," "estimate," "predict," "potential" or "continue," the negative of such terms, or other comparable terminology. These statements are only predictions. Actual events or results may differ materially from those in the forward-looking statements as a result of various important factors. Although we believe that the expectations reflected in the forward-looking statements are reasonable, they should not be regarded as a representation by CoroWare, Inc., or any other person, that such expectations will be achieved. The business and operations of CoroWare, Inc. are subject to substantial risks, which increase the uncertainty inherent in the forward-looking statements contained in this report.

BACKGROUND

CoroWare, Inc ("CoroWare" or "the Company") is a public holding company whose principal subsidiary, CoroWare Technologies, Inc. ("CTI"), has expertise in information technology consulting, mobile robotics, and affordable telepresence. Through its subsidiary, the Company delivers custom engineering services, hardware and software products, and subscription services that benefit customers in North America, Europe, Asia, Australia and the Middle East. Their customers span multiple industry sectors and are comprised of universities, software and hardware product development companies, and non-profit organizations. The company also maintains a Near Shore practice which is comprised of multiple subcontracting companies with whom the company maintains close working relationships. Through these relationships, the Company is able to provide services in South America.

COROWARE TECHNOLOGIES, INC.

CTI is a software professional services company with a strong focus on Information Technology integration and robotics integration, business automation solutions, and unmanned systems solutions to its customers in North America and Europe.

CTI’s expertise includes the deployment and integration of computing platforms and applications, as well as the development of unmanned vehicle software and solutions for customers in the research, commercial, and homeland security market segments. CTI shall continue to offer its high value software systems development and integration services that complement the growing trend in outsourced software development services in Asia, Latin America, and Eastern Europe.

CoroWare Technologies comprises three separately managed lines of business:

CoroWare Business Solutions: IT and lab management; business intelligence, software architecture, design and development; content delivery; partner and program management.

Robotics and Automation: Custom engineering such as visualization, simulation and software development; and mobile robot platforms for university, government and corporate researchers..

Enhanced Collaboration Solution: Collaboration and conferencing products, solutions and subscription services.

The Company’s revenues are principally derived from standing contracts that include Microsoft (partner management and IT professional services), a European auto manufacturer (simulation software custom development), and other customers whose product development groups require custom software development and consulting companies. Existing contract revenues vary month by month based on the demands of the clients. The Company’s collaboration effort is in the early stages of growth and will require additional working capital to compete effectively against new entrants in this rapidly growing market.

RESULTS OF OPERATIONS

THREE MONTHS ENDED SEPTEMBER 30, 2012 COMPARED TO THREE MONTHS ENDED SEPTEMBER 30, 2011:

During the three-month period ended September 30, 2012 (the "2012 Period") revenues were $224,136 compared to revenues of $389,089 during the three-month period ended September 30, 2011 (the "2011 Period"). Our revenues were 42.4% lower compared to the previous year as customers continued to delay spending on software development projects. As well, a significant number of videoconferencing and mobile robot product shipments were postponed in the third quarter of 2012 until the fourth quarter of 2012.

Cost of revenues was $179,098 for the 2012 Period compared to $289,945 for the 2011 Period. Cost of revenues represents primarily labor and labor-related costs in addition to overhead costs. Gross profit on these 2012 revenues amounted to $45,038 (20.1% gross profit percentage) compared to $99,144 (25.5% gross profit percentage) for the 2011 Period.

Research and development was $12,309 (5.5% of gross revenues) for the 2012 Period compared to $20,372 (5.2% of gross revenues) in the 2011 Period, and comprised development of mobile robot and billing mediation application software.

Operating expenses were $250,181 during the 2012 Period compared to $274,784 during the 2011 Period. General and Administration expenses were reduced by 2.7% to $177,636 in the 2012 Period compared to $182,588 for the 2011 Period as the Company continued to reduce its executive compensation and public company expenses. Sales and marketing expenses were reduced by 16.8% to $57,236 in the 2012 Period compared to $68,824 for the 2011 Period as the Company further refined sales compensation plans to bring them in line with the Company’s cost of sales objectives. Loss from operations was $205,143during the 2012 Period compared to $175,640 in the 2011 Period.

Total other expense was $6,294,769 during the 2012 Period compared to Total other expense of $2,760,329 in the 2011 Period. Other income (expense) is comprised primarily of derivative income and amortization of debt discount and deferred finance costs. Derivative expense in the 2012 Period was $6,228,894 compared to Derivative expense of $2,561,925 in the 2011 Period. Keeping the number of shares constant, the liability associated with the embedded conversion features increases as our share price and volatility increases and, likewise, decreases when our share price and share price volatility decreases. Derivative income (expense) displays the inverse relationship. During the 2012 Period, the share price decreased ($.0028 at September 30, 2012 versus $0.02 at June 30, 2012) with consistent volatility, which resulted in a significant change in the calculated Monte Carlo values. The derivative expense in the 2012 Period is primarily due to fair value adjustments to the embedded conversion features. Interest expense for the three month 2012 Period is $157,303 compared to $198,518 for the three month 2011 Period. The debt discount was amortized using the effective interest method. Under this method, the amount of amortization increases exponentially as the underlying carrying value of the amortized debt increases.

Net Loss for the 2012 Period was $6,499,912 compared to a net loss of $2,935,969 for the 2011 Period.

Basic weighted average shares outstanding were 23,689,883 shares during the 2012 Period compared to 4,705,474 shares in the 2011 Period. There is no fully diluted calculation for the 2012 Period or the 2011 Period as the effect would be anti-dilutive.

NINE MONTHS ENDED SEPTEMBER 30, 2012 COMPARED TO NINE MONTHS ENDED SEPTEMBER 30, 2011:

During the nine-month period ended September 30, 2012 (the "2012 Period"), revenues were $910,655 compared to revenues of $1,277,358 during the nine-month period ended September 30, 2012 (the "2011 Period"). Our revenues were 28.7% lower compared to the previous year as customers delayed spending on software development projects, IT consulting engagements, software development projects, and capital expenditures until later in the calendar year. As well, a significant number of videoconferencing and mobile robot product shipments were postponed in the third quarter of 2012 until the fourth quarter of 2012.

Cost of revenues was $595,459 for the 2012 Period compared to $849,347 for the 2011 Period. Cost of revenues represents primarily labor and labor-related costs in addition to overhead costs. Gross profit on these 2012 revenues amounted to $ 315,196 (34.6% gross profit percentage) compared to $428,011 (33.5% gross profit percentage) for the 2011 Period.

Research and development was $57,391 (6.3% of gross revenues) for the 2012 Period compared to $106,562 (8.3% of gross revenues) in the 2011 Period.

Operating expenses were $775,375 during the 2012 Period compared to $1,036,048 during the 2011 Period. General and Administration expenses were reduced by 21.6% to $516,109 in the 2012 Period compared to $658,083 for the 2011 Period as the Company reduced its executive compensation and public company auditing expenses. Sales and marketing expenses were reduced by 23.3% to $192,875 in the 2012 Period compared to $251,322 for the 2011 Period as the Company further adjusted sales compensation plans to bring them in line with the Company’s cost of sales objectives. Loss from operations was $460,179during the 2012 Period compared to $608,037 in the 2011 Period.

Total other expense was $7,497,690 during the 2012 Period compared to other expense of $3,590,548 in the 2011 Period. Other income (expense) is comprised primarily of derivative income and amortization of debt discount and deferred finance costs. Derivative expense in the 2012 Period was $6,568,388 compared to derivative expense of $3,021,883 in the 2011 Period. Keeping the number of shares constant, the liability associated with the embedded conversion features increases as our share price and volatility increases and, likewise, decreases when our share price and share price volatility decreases. Derivative income (expense) displays the inverse relationship. During the 2012 Period, the share price decreased ($.0028 at September 30, 2012 versus $0.02 at December 31, 2011) with consistent volatility, which resulted in a significant change in the calculated Monte Carlo values. The derivative expense in the 2012 Period is primarily due to expense recognized in connection with redemptions on various debentures during the Period. Interest expense for the nine month 2012 Period is $527,021 compared to $567,600 for the nine month 2011 Period. The debt discount was amortized using the effective interest method. Under this method, the amount of amortization increases exponentially as the underlying carrying value of the amortized debt increases.

Net Loss for the 2012 Period was $ ($7,497,690) compared to a net loss of $4,198,586 for the 2011 Period.

Basic weighted average shares outstanding were 14,126,220 during the 2012 Period compared to 2,503,438 in the 2011 Period. There is no fully diluted calculation for the 2012 Period or the 2011 Period as the effect would be anti-dilutive.

LIQUIDITY AND CAPITAL RESOURCES

At September 30, 2012, we had current assets of $167,391, current liabilities of $18,471,226, negative working capital of $18,303,835 and an accumulated deficit of $34,964,256. For the nine months ending September 30, 2012, we had net cash flows used in operating activities of ($88,837), net cash flows used in investing activities of ($1,371), and net cash flows provided by financing activities of $92,613.

We will need to obtain additional capital in order to expand operations and become profitable. In order to obtain capital, we may need to sell additional shares of our common stock or borrow funds from private lenders. There can be no assurance that we will be successful in obtaining additional funding. We will still need additional capital in order to continue operations until we are able to achieve positive operating cash flow. Additional capital is being sought, but we cannot guarantee that we will be able to obtain such investments. Financing transactions may include the issuance of equity or debt securities, obtaining credit facilities, or other financing mechanisms. If we do not obtain additional capital, we may cease operations.

However, even if we are able to raise the funds required, it is possible that we could incur unexpected costs and expenses, fail to collect significant amounts owed to us, or experience unexpected cash requirements that would force us to seek alternative financing. Furthermore, if we issue additional equity or debt securities, stockholders may experience additional dilution or the new equity securities may have rights, preferences or privileges senior to those of existing holders of our common stock. If additional financing is not available or is not available on acceptable terms, we will have to curtail our operations.

OFF-BALANCE SHEET ARRANGEMENTS

We do not have any off balance sheet arrangements that are reasonably likely to have a current or future effect on our financial condition, revenues, results of operations, liquidity or capital expenditures.

CONTRACTUAL OBLIGATIONS

The following table sets forth the contractual obligations of the Company as of December 31, 2011:

	Payments due by Period
Contractual Obligations	Total		Less than 1 year		1-3 years		3-5 years		More than 5 years
Convertible debt, net	$	2,292,410	$	2,292,410	$	-	$	-	$	-
Notes payable		263,133		263,133		-		-		-
Notes payable, related parties		292,812		292,812		-		-		-
Operating leases		235,305		46,065		101,094		88,146		-
Long –term debt		982,450		982,450		-		-		-
Total	$	4,066,110	$	3,876,870	$	101,094	$	88,146	$	-

EFFECT OF RECENT ACCOUNTING PRONOUNCEMENTS

Refer to Form 10-K for the year ended December 31, 2011.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

As a smaller reporting company, as defined in Rule 12b-2 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), we are not required to provide the information required by this item.

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

With the participation of Lloyd T. Spencer, who serves as the Chief Executive Officer (the principal executive officer) and Interim Chief Financial Officer (the principal financial officer); the Company’s management has evaluated the effectiveness of the Company’s disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), as of the end of the quarterly period covered by this Quarterly Report on Form 10-Q. As of the end of the period covered by this Report, we conducted an evaluation, under the supervision and with the participation of our chief executive officer and interim chief financial officer, of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934). Based on this evaluation, our chief executive officer and interim chief financial officer concluded that our disclosure controls and procedures are not effective to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms. The ineffectiveness of our disclosure controls and procedures is the result of certain deficiencies in internal controls constituting material weaknesses as discussed below.

The Company has historically had limited operating revenue and, as such, all accounting and financial reporting operations have been and are currently performed by a limited number of individuals. The parties that perform the accounting and financial reporting operations are the only parties with any significant knowledge of generally accepted accounting principles. Thus, we lack segregation of duties in the period-end financial reporting process. This lack of additional accounting/auditing staff with significant knowledge of generally accepted accounting principles in order to properly segregate duties could result in ineffective oversight and monitoring and the possibility of a misstatement within the consolidated financial statements. However, the material weaknesses identified did not result in the restatement of any previously reported financial statements or any other related financial disclosure, nor does management believe that it had any effect on the accuracy of the Company's consolidated financial statements for the current reporting period.

The Company is currently reviewing its policies and is evaluating its disclosure controls and procedures so that it will be able to determine the changes it can and should make to make such controls more effective.

Changes in Internal Controls over Financial Reporting

There were no changes in the Company's internal control over financial reporting during the Company's last fiscal quarter that have materially affected, or are likely to materially affect, the Company's internal control over financial reporting.

Part II – OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

None.

ITEM 1A. RISK FACTORS

As a smaller reporting company, as defined in Rule 12b-2 of the Exchange Act, we are not required to provide the information required by this item.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF FUNDS

None.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

(a)	As of the balance sheet date the company is in arrears in the payment of dividends related to its Series B preferred stock in the amount of $15,969.

(b)

At September 30, 2012, we are in default on the remaining of the original $2,825,000 Secured Convertible Debenture presently held by Yorkville Advisors, LLC. Yorkville currently holds $395,628 of the first tranche and $82,630 of the third tranche. The remainder of the first tranche was assigned to a third party (“Ratzker”) who amended the terms in March 2011 extending the maturity date to March 2013. During the second quarter of 2011, Ratzker assigned 50% of his note to another third party (“Redwood”). The second tranche was assigned to a third party who did not amend the terms. The note is still in default. The debenture accrued interest at 10% per annum thru March 25, 2008 at which time the interest rate was increased to 14% per annum. The debenture is convertible at the option of the holder into shares of CoroWare, Inc. common stock.

(c)	As of September 30, 2012, we are in default on our Secured Convertible Debenture presently held by Yorkville Advisors, LLC in the face amount of $600,000. The debenture accrued interest at 14% per annum and is convertible at the option of the holder into shares of CoroWare, Inc. common stock.

(d)	As of September 30, 2012, we are in default on our Secured Convertible Debenture presently held by Yorkville Advisors, LLC in the face amount of $300,000. The debenture accrued interest at 14% per annum and is convertible at the option of the holder into shares of CoroWare, Inc. common stock.

(e)

As of September 30, 2012, we are in default on our Unsecured Convertible Debenture presently held by Barclay Lyons in the face amount of $10,750. The debenture accrued interest at 21% through the maturity date of July 28, 2011 with default interest at 35% thereafter. The debenture is convertible at the option of the holder into shares of CoroWare, Inc. common stock.

(f)

As of September 30, 2012, we are in default on our Unsecured Convertible Debenture presently held by Martin Harvey in the face amount of $67,042. The debenture accrued interest at 10% through the maturity date of May 2, 2011 with default interest at 15% thereafter. The debenture is convertible at the option of the holder into shares of CoroWare, Inc. common stock.

(g)	As of September 30, 2012, we are in default on our Unsecured Convertible Debenture presently held by Thomas Collins in the face amount of $39,170. The debenture accrues interest at 15% and is convertible at the option of the holder into shares of CoroWare, Inc. common stock.

(h)

As of September 30, 2012, we are in default on our Unsecured Convertible Debenture presently held by Premier IT Solutions in the face amount of $21,962. The debenture accrues interest at 10% through the maturity date of March 5, 2012 and accrues default interest at 15% thereafter. The note is convertible at the option of the holder into shares of CoroWare, Inc. common stock

(i)

As of September 30, 2012, we are in default on two notes payable aggregating $100,000. The notes accrued interest at 8% through the maturity date of February 2003 with default interest at 15% thereafter. The notes are convertible at the option of the holder into shares of CoroWare, Inc. common stock.

ITEM 4. MINE SAFETY DISCLOSURES

None.

ITEM 5. OTHER INFORMATION

None.

ITEM 6. EXHIBITS

31		Certification of Periodic Financial Reports by Lloyd Spencer in satisfaction of Section 302 of the Sarbanes-Oxley Act of 2002
32		Certification of Periodic Financial Reports by Lloyd Spencer in satisfaction of Section 906 of the Sarbanes-Oxley Act of 2002 and 18 U.S.C. Section 1350

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	CoroWare, Inc.


Dated: June 18, 2013	/s/ Lloyd T. Spencer
		Lloyd T. Spencer, Chief Executive Officer and Interim Chief Financial Officer (Principal Executive Officer and Principal Accounting and Financial Officer)